Over the years, you’ve probably heard me get excited about DHEA (dehydroepiandrosterone) for one reason or another.
(Partly because I’ve personally benefitted from taking it, so I am admittedly biased.)
This new study builds on the trend we’ve been discussing—that DHEA is an immune modulator—so I thought you might want to know about this new article.
Researchers in Europe gave DHEA or no treatment to older men with autoimmune thyroid disease for six months. The men in the treatment group had statistically significant reductions in markers of autoimmunity compared to the men in the control group.
Related: Support Adrenal Health with MYOXCIENCE's Adrenal Glandular
The men in the DHEA treatment arm also showed significant increases in testosterone compared to the men who weren’t receiving the therapy.
Here’s links to the article mentioned above, as I thought you might be interested:
Brahimaj, A., Muka, T., Kavousi, M., Laven, J. S. E., Dehghan, A., & Franco, O. H. (2016). Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study. Diabetologia, 1–9.
Jankowska, K., Maksym, R., & Zgliczyński, W. (2019). Dehydroepiandrosterone can restore the function of the ovaries – a series of 5 cases and a review of the literature. Journal of Obstetrics and Gynecological Investigations, 2(1), 11–18.
Krysiak, R., Szkróbka, W., & Okopień, B. (2020). Impact of dehydroepiandrosterone on thyroid autoimmunity and function in men with autoimmune hypothyroidism. International Journal of Clinical Pharmacy, 1–8.